Life Science News

Latest updates from the biotech and pharma world

Endpoints News 2026-02-25

Charles River sells its CDMO and European discovery businesses

Endpoints News 2026-02-25

Accent axes a cancer study; Werewolf considers its options

Endpoints News 2026-02-25

Alkermes CEO Richard Pops to retire after 35-year tenure

Endpoints News 2026-02-25

States sue Kennedy over US childhood vaccine overhaul

Endpoints News 2026-02-25

Novo Nordisk teams with Langer-founded biotech for oral obesity drugs

Endpoints News 2026-02-25

Polymer nanoparticle startup BreezeBio raises $60M for mRNA diabetes therapy

Endpoints News 2026-02-25

GSK to buy pulmonary hypertension biotech 35Pharma for $950M

Endpoints News 2026-02-24

HHS commits up to $144M to study anti-aging approaches via ARPA-H

Endpoints News 2026-02-24

Novo Nordisk to slash Wegovy list price in half in 2027

Endpoints News 2026-02-24

Industry groups lay legal groundwork against pricing demos

Endpoints News 2026-02-24

UCLA spinout raises $11M to test microbiome-based weight loss therapy

Endpoints News 2026-02-24

Can the ACCESS pilot crack a longstanding barrier for startups?

Endpoints News 2026-02-24

BioMarin fails to find buyer, pulls Roctavian gene therapy off market

Endpoints News 2026-02-24

Patient dies in MacroGenics' cancer study, FDA puts trial on hold

Endpoints News 2026-02-24

Beam Therapeutics' new PKU program; Protara's bladder cancer data

Endpoints News 2026-02-24

Abcuro drug fails muscle weakness trial, development to continue

Endpoints News 2026-02-24

Immedica wins accelerated approval for once-rejected rare disease drug

Endpoints News 2026-02-24

New biotech Slate Medicines raises $130M for migraine drug from China

Endpoints News 2026-02-24

Novo Nordisk’s triple-G is competitive with Lilly in obesity, but likely to be second to market

Endpoints News 2026-02-24

Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push

-604 / 35